Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Development, characterization and clinical validation of new sensitive immunofluorometric assay for the measurement of serum thyroglobulin.

Nakabashi CC, Biscolla RP, Kasamatsu TS, Tachibana TT, Barcelos RN, Malouf EZ, Andreoni DM, Maciel RM, Vieira JG.

Arq Bras Endocrinol Metabol. 2012 Dec;56(9):658-65.

2.
3.

Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma.

Giovanella L, Maffioli M, Ceriani L, De Palma D, Spriano G.

Clin Chem Lab Med. 2009;47(8):1001-4. doi: 10.1515/CCLM.2009.216.

PMID:
19589104
7.

A sensitive Tg assay or rhTSH stimulated Tg: what's the best in the long-term follow-up of patients with differentiated thyroid carcinoma?

Persoon AC, Jager PL, Sluiter WJ, Plukker JT, Wolffenbuttel BH, Links TP.

PLoS One. 2007 Aug 29;2(8):e816.

8.

Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.

Giovanella L, Ceriani L, Suriano S, Ghelfo A, Maffioli M.

Clin Endocrinol (Oxf). 2008 Oct;69(4):659-63. doi: 10.1111/j.1365-2265.2008.03244.x. Epub 2008 Mar 18.

PMID:
18363882
9.

Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma.

Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R.

Cancer. 2003 Jan 1;97(1):90-6.

PMID:
12491509
10.

Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer.

Iervasi A, Iervasi G, Ferdeghini M, Solimeo C, Bottoni A, Rossi L, Colato C, Zucchelli GC.

Clin Endocrinol (Oxf). 2007 Sep;67(3):434-41. Epub 2007 Jun 6.

PMID:
17555505
11.

[On-levothyroxine measurement of thyroglobulin is not a reliable test for the follow-up of patients at high risk for remnant/recurrent differentiated thyroid carcinoma].

Gholamrezanezhad A, Saghari M, Mirpour S, Beiki D, Tarbiat A, Javan S, Abdollahzadeh J.

Endokrynol Pol. 2007 Mar-Apr;58(2):100-4.

PMID:
17578824
12.

Molecular technology and the recombinant TSH have changed diagnostics of thyroid carcinoma with positive I-131 whole body scan but low serum thyroglobulin.

Montella L, Caraglia M, Abbruzzese A, Soricelli A, Prete SD, Squame G, Salvatore M.

Exp Mol Med. 2004 Jun 30;36(3):268-73.

13.

Follow-up of differentiated thyroid carcinoma.

Pagano L, Klain M, Pulcrano M, Angellotti G, Pasano F, Salvatore M, Lombardi G, Biondi B.

Minerva Endocrinol. 2004 Dec;29(4):161-74. Review. English, Italian.

14.

Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.

Giovanella L, Ceriani L, Ghelfo A, Maffioli M, Keller F.

Clin Endocrinol (Oxf). 2007 Oct;67(4):547-51. Epub 2007 Jun 11.

PMID:
17561976
15.

An evaluation of the value of first thyroglobulin determination in the diagnostics of metastases immediately following differentiated thyroid carcinoma surgery.

Makarewicz J, Adamczewski Z, Rutkowski A, Mikosiński S, Knapska-Kucharska M, Gonerska-Szadkowska A, Oszukowska L, Karwowska A, Lewiński A.

Endokrynol Pol. 2006 Jul-Aug;57(4):370-3.

PMID:
17006838
16.
17.
19.
20.

Clinical utility of an automated immunochemiluminometric thyroglobulin assay in differentiated thyroid carcinoma.

Persoon AC, Van Den Ouweland JM, Wilde J, Kema IP, Wolffenbuttel BH, Links TP.

Clin Chem. 2006 Apr;52(4):686-91.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk